WallStreetZenWallStreetZen

NASDAQ: GOVX
Geovax Labs Inc Stock

Overview
ForecastEarningsDividendOwnership
$0.61-0.01 (-1.61%)
Updated Jun 5, 2023
GOVX Price
$0.61
Fair Value Price
$5.14
Market Cap
$16.13M
52 Week Low
$0.53
52 Week High
$4.30
P/E
-0.87x
P/B
0.71x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$15.63M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.2
Operating Cash Flow
-$18M
Beta
-0.02
Next Earnings
Aug 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

GOVX Overview

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Zen Score

–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GOVX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GOVX ($0.61) is undervalued by 88.12% relative to our estimate of its Fair Value price of $5.14 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GOVX ($0.61) is significantly undervalued by 88.12% relative to our estimate of its Fair Value price of $5.14 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
GOVX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GOVX due diligence checks available for Premium users.

Be the first to know about important GOVX news, forecast changes, insider trades & much more!

GOVX News

Valuation

GOVX fair value

Fair Value of GOVX stock based on Discounted Cash Flow (DCF)
Price
$0.61
Fair Value
$5.14
Undervalued by
88.12%
GOVX ($0.61) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GOVX ($0.61) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GOVX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GOVX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.87x
Industry
11.59x
Market
53.21x

GOVX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.71x
Industry
5.21x
GOVX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GOVX's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.0M
Profit Margin
0%
GOVX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$27.4M
Liabilities
$4.5M
Debt to equity
0.2
GOVX's short-term assets ($25.99M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GOVX's short-term assets ($25.99M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GOVX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GOVX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.8M
Investing
$0.0
Financing
$0.0
GOVX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GOVX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GOVX$16.13M-1.61%-0.87x0.71x
TFFP$16.29M-5.66%-0.49x0.98x
FRES$15.82M-2.31%-0.59x-8.04x
CVKD$16.53M+2.92%N/A4.07x
INFI$15.46M-4.44%-0.36x-0.55x
View Top Biotech Stocks

Geovax Labs Stock FAQ

What is Geovax Labs's quote symbol?

(NASDAQ: GOVX) Geovax Labs trades on the NASDAQ under the ticker symbol GOVX. Geovax Labs stock quotes can also be displayed as NASDAQ: GOVX.

If you're new to stock investing, here's how to buy Geovax Labs stock.

What is the 52 week high and low for Geovax Labs (NASDAQ: GOVX)?

(NASDAQ: GOVX) Geovax Labs's 52-week high was $4.30, and its 52-week low was $0.53. It is currently -85.81% from its 52-week high and 14.88% from its 52-week low.

How much is Geovax Labs stock worth today?

(NASDAQ: GOVX) Geovax Labs currently has 26,443,649 outstanding shares. With Geovax Labs stock trading at $0.61 per share, the total value of Geovax Labs stock (market capitalization) is $16.13M.

Geovax Labs stock was originally listed at a price of $1,062,500,000.00 in Dec 31, 1997. If you had invested in Geovax Labs stock at $1,062,500,000.00, your return over the last 25 years would have been -100%, for an annualized return of -57.31% (not including any dividends or dividend reinvestments).

How much is Geovax Labs's stock price per share?

(NASDAQ: GOVX) Geovax Labs stock price per share is $0.61 today (as of Jun 5, 2023).

What is Geovax Labs's Market Cap?

(NASDAQ: GOVX) Geovax Labs's market cap is $16.13M, as of Jun 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Geovax Labs's market cap is calculated by multiplying GOVX's current stock price of $0.61 by GOVX's total outstanding shares of 26,443,649.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.